Published on in Vol 4, No 9 (2020): September
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/18118, first published
.
Journals
- Fattakhov N, Torices S, Stangis M, Park M, Toborek M. Synergistic Impairment of the Neurovascular Unit by HIV-1 Infection and Methamphetamine Use: Implications for HIV-1-Associated Neurocognitive Disorders. Viruses 2021;13(9):1883 View
- Viamonte M, Ghanooni D, Reynolds J, Grov C, Carrico A. Running with Scissors: a Systematic Review of Substance Use and the Pre-exposure Prophylaxis Care Continuum Among Sexual Minority Men. Current HIV/AIDS Reports 2022;19(4):235 View
- Frank N, McMahan V, Violette L, Martin A, Glick S, Stekler J. Efficient Expansion of a Behavioral Survey to Assess Sex, Gender, and Behavioral Risk Among Transgender and Nonbinary Individuals: HMU! (HIV Prevention for Methamphetamine Users). Transgender Health 2023;8(5):472 View
- Zamantakis A, Li D, Benbow N, Smith J, Mustanski B. Determinants of Pre-exposure Prophylaxis (PrEP) Implementation in Transgender Populations: A Qualitative Scoping Review. AIDS and Behavior 2023;27(5):1600 View
- Oliveira R, Silva L, Duarte F, Brasil S, Castellanos M, Magno L, Dourado I. Building bridges to care: the experience of peer navigation in enabling linkage to PrEP for adolescent men who have sex with men and transgender women. Cadernos de Saúde Pública 2023;39(suppl 1) View
- McMahan V, Atkins D, Buckler S, Violette L, Niemann L, Frank N, Kimiam Waters , Herrera Perales L, Viquez L, Tung E, Stekler J. Challenges recruiting and retaining people at risk for HIV who use methamphetamine in a randomized PrEP adherence trial in Seattle, WA. International Journal of STD & AIDS 2024;35(8):635 View